Salt Creek Capital

Salt Creek Capital is a U.S.-based private equity firm that acquires and invests in lower middle-market private companies, typically in ownership transition or succession situations. The firm partners with operating executives through an Executive Partner Program and focuses on control investments rather than building a proprietary therapeutic pipeline. Its sector coverage is broad and includes manufacturing, business services, distribution, food and beverage, franchising, technology-related services, and healthcare services. In healthcare, Salt Creek appears to invest at the company level rather than as a drug developer, with recent activity including healthcare services and diagnostics assets such as Real Diagnostics. It is not a biotech, pharma, or life sciences product company.